Cargando…

Simulations of symptomatic treatments for Alzheimer's disease: computational analysis of pathology and mechanisms of drug action

INTRODUCTION: A substantial number of therapeutic drugs for Alzheimer's disease (AD) have failed in late-stage trials, highlighting the translational disconnect with pathology-based animal models. METHODS: To bridge the gap between preclinical animal models and clinical outcomes, we implemented...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roberts, Patrick D, Spiros, Athan, Geerts, Hugo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580459/ https://www.ncbi.nlm.nih.gov/pubmed/23181523 http://dx.doi.org/10.1186/alzrt153

Ejemplares similares

A biophysically realistic computer model of Alzheimer pathology to guide the development of symptomatic drugs
por: Roberts, Patrick D, et al.
Publicado: (2012)

A strategy for developing new treatment paradigms for neuropsychiatric and neurocognitive symptoms in Alzheimer’s disease
por: Geerts, Hugo, et al.
Publicado: (2013)

Impact of amyloid-beta changes on cognitive outcomes in Alzheimer’s disease: analysis of clinical trials using a quantitative systems pharmacology model
por: Geerts, Hugo, et al.
Publicado: (2018)

A computer-based quantitative systems pharmacology model of negative symptoms in schizophrenia: exploring glycine modulation of excitation-inhibition balance
por: Spiros, Athan, et al.
Publicado: (2014)

Blinded Prospective Evaluation of Computer-Based Mechanistic Schizophrenia Disease Model for Predicting Drug Response
por: Geerts, Hugo, et al.
Publicado: (2012)

Learning from amyloid trials in Alzheimer's disease. A virtual patient analysis using a quantitative systems pharmacology approach
por: Geerts, Hugo, et al.
Publicado: (2020)

A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson’s Disease
por: Roberts, Patrick, et al.
Publicado: (2016)

Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacology
por: Geerts, Hugo, et al.
Publicado: (2015)

Not all partial dopamine D(2) receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse
por: Spiros, Athan, et al.
Publicado: (2010)

A quantitative way to estimate clinical off-target effects for human membrane brain targets in CNS research and development
por: Spiros, Athan, et al.
Publicado: (2012)

F189. PERSONALIZED MEDICINE: ESTIMATING THE IMPACT OF GENOTYPES ON ANTIPSYCHOTIC EFFICACY USING A QUANTITATIVE SYSTEMS PHARMACOLOGY APPROACH
por: Geerts, Hugo, et al.
Publicado: (2018)

Toward Predicting Impact of Common Genetic Variants on Schizophrenia Clinical Responses With Antipsychotics: A Quantitative System Pharmacology Study
por: Spiros, Athan, et al.
Publicado: (2021)

Has the Time Come for Predictive Computer Modeling in CNS Drug Discovery and Development?
por: Geerts, H, et al.
Publicado: (2012)

S221. QUANTITATIVE SYSTEMS PHARMACOLOGY AS AN ALTERNATIVE TO CHLORPROMAZINE EQUIVALENTS: PREDICTIVE VALIDATION FROM A CRIS DATABASE EXPERIMENT
por: Geerts, Hugo, et al.
Publicado: (2018)

A Quantitative System Pharmacology Computer Model for Cognitive Deficits in Schizophrenia
por: Geerts, H, et al.
Publicado: (2013)

Predicting parkinsonism side-effects of antipsychotic polypharmacy prescribed in secondary mental healthcare
por: Kadra, Giouliana, et al.
Publicado: (2018)

Pathological Aspects of Neuronal Hyperploidization in Alzheimer’s Disease Evidenced by Computer Simulation
por: Barrio-Alonso, Estíbaliz, et al.
Publicado: (2020)

Computational Approaches for Supporting Combination Therapy in the Post-Aducanumab Era in Alzheimer’s Disease
por: Geerts, Hugo, et al.
Publicado: (2021)

Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives
por: Femminella, Grazia Daniela, et al.
Publicado: (2017)

The Computer Simulation of Therapy with the NMDA Antagonist in Excitotoxic Neurodegeneration in an Alzheimer’s Disease-like Pathology
por: Świetlik, Dariusz, et al.
Publicado: (2022)

New approaches to symptomatic treatments for Alzheimer’s disease
por: Cummings, Jeffrey
Publicado: (2021)

Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies
por: Buccellato, Francesca R., et al.
Publicado: (2023)

Symptomatic Pathology of the Mouth
por: Smilie, Elton R.
Publicado: (1885)

Symptomatic Pathology of the Mouth
por: Smilie, Elton R.
Publicado: (1885)

Correction to: New approaches to symptomatic treatments for Alzheimer’s disease
por: Cummings, Jeffrey
Publicado: (2021)

Analysis of the Molecular Mechanism of Punicalagin in the Treatment of Alzheimer’s Disease by Computer-Aided Drug Research Technology
por: Xu, Ping, et al.
Publicado: (2022)

Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression
por: Peng, Guo-jiang, et al.
Publicado: (2015)

Neurons In Action: Computer Simulations with NeuroLab
por: Barry, Susan R.
Publicado: (2004)

Real-World Use of Symptomatic Treatments in Early Alzheimer’s Disease
por: Garcia, Maria João, et al.
Publicado: (2023)

Patterns of use of symptomatic treatments for Alzheimer's disease dementia (AD)
por: DiBello, Julia R., et al.
Publicado: (2023)

Computer-Aided Screening and Revealing Action Mechanism of Green Tea Polyphenols Intervention in Alzheimer’s Disease
por: Wang, Min, et al.
Publicado: (2023)

Prediction of Efficacy of Vabicaserin, a 5-HT(2C) Agonist, for the Treatment of Schizophrenia Using a Quantitative Systems Pharmacology Model
por: Liu, J, et al.
Publicado: (2014)

Arthroscopic Treatment of Symptomatic Internal Snapping Hip with Combined Pathologies
por: Hwang, Duck-Soo, et al.
Publicado: (2015)

Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer's disease
por: Wu, Qihui, et al.
Publicado: (2023)

Alzheimer’s Disease: Pathological Mechanisms and Recent Insights
por: Niedowicz, Dana M, et al.
Publicado: (2011)

Pathological mechanisms and therapeutic strategies for Alzheimer’s disease
por: Ju, Yaojun, et al.
Publicado: (2021)

Unraveling the Binding Mechanism of Alzheimer’s Drugs with Irisin: Spectroscopic, Calorimetric, and Computational Approaches
por: Waseem, Rashid, et al.
Publicado: (2022)

Natural Products for Treatment of Alzheimer's Disease and Related Diseases: Understanding their Mechanism of Action
por: Shao, Rong, et al.
Publicado: (2013)

Investigating Interventions in Alzheimer's Disease with Computer Simulation Models
por: Proctor, Carole J., et al.
Publicado: (2013)

Action simulation: time course and representational mechanisms
por: Springer, Anne, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_u4j6pvavqr0r48t3ol931tvoe9